Skip to content

Clinical trials

Hyperlipidemias trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Country / region: Poland Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20054
20061
20081
20111
20135
20141
20161
20171
20181
20201
20212
20221
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated3
Active, not recruiting2
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer6
Novartis Pharmaceuticals4
Takeda4
Amgen3
89bio, Inc.1
AstraZeneca1
Esperion Therapeutics, Inc.1
Ionis Pharmaceuticals, Inc.1
Medical University of Silesia1
Poznan University of Medical Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias26
Hypercholesterolemia9
Dyslipidemias8
Cardiovascular Diseases4
Metabolic Diseases3
Myocardial Infarction3
Stroke3
Atherosclerosis2
Coronary Artery Disease2
Diabetes Mellitus, Type 22

Trials

Showing 51 to 26 of 26. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.